20:01 EDT Cathie Wood’s ARK Investment bought 137K shares of Intellia Therapeutics today
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTLA:
- Biotech Alert: Searches spiking for these stocks today
- Cathie Wood’s ARK Investment bought 174K shares of Intellia Therapeutics today
- Intellia announces long-term data from ongoing Phase 1 study of NTLA-2002
- Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)
- Intellia Therapeutics price target lowered to $29 from $31 at Citi